Cart
0

Russia In Vitro Fertilization (IVF) Market by End User (Fertility Clinics, Hospitals, Surgical Centers, and Clinical Research Institutes), Cycle Type (Fresh IVF Cycles (Non-donor), Thawed IVF Cycles (Non-donor), and Donor Egg IVF Cycles), Type (Non-intracytoplasmic Sperm Injection (ICSI) IVF Cycles, and ICSI-Assisted IVF Cycles), Drug (Clomiphene Citrate, Aromatase Inhibitors, Gonadotropins & Gonadotropin-releasing Hormone, Follicle-stimulating Hormone, Progesterone, and Others), and Mode of Administration (Oral, Injectable, and Vaginal) - Opportunity Analysis and Industry Forecast, 2014-2022

Get 20% Free Customization In This Report
LI_172389
Pages: 77
Jul 2017 | 2477 Views
 
Author's : Onkar Sumant and Sohail Shaikh
Tables: 21
Charts: 28
 

Russia IVF Market Overview:

The Russia IVF Market was valued at $398 million in 2015, and is estimated to reach $641 million by 2022, registering a CAGR of 7.0% from 2016 to 2022. In vitro fertilization (IVF) is the process of artificial fertilization used to treat infertility problems. It is the most efficient assisted reproductive technology (ART) that aids couples or single parents to conceive a child. However, this procedure does not always provide successful results, and its success rate varies from individual to individual.

IVF has emerged as a preferable choice for fertility treatment in the clinical industry. This procedure is performed in a clinical laboratory where the matured egg (self-egg or donors egg) is fertilized with the sperm (self-sperm or donors sperm). The fertilized egg or embryo is then implanted into the uterus.

The Russia IVF market is driven by the low-cost clinical settings for IVF treatments as compared to treatment facilities in the U.S., UK, and other established markets. Rise in popularity of medical and fertility tourism, coupled with advanced IVF facilities and treatment options, supplements the market growth.

Russia IVF Market Segmentation

RUSSIA IVF MARKET SEGMENTATION

Get more information on this report : Request Sample Pages

The Russia IVF market is segmented based on end user, cycle type, type, drug, and mode of administration. Based on end user, it is divided into fertility clinics, hospitals, surgical centers, and clinical research institutes. On the basis of cycle type, it is classified into fresh IVF cycles (non-donor), thawed IVF cycles (non-donor), and donor egg IVF cycles. The type segment includes non-ICSI IVF cycles and ICSI-assisted IVF cycles. On the basis of drug, the market is categorized into clomiphene citrate, aromatase inhibitors, gonadotropins & gonadotropin-releasing hormone, follicle-stimulating hormone, progesterone, and others. Based on mode of administration, this market is analyzed through oral, injectable, and vaginal modes.

The market is expected to witness moderate growth during the forecast period, owing to the rise in adoption of IVF systems in Russia due to growth in medical and fertility tourism. Rise in willingness of single parents and same-sex couples to experience parenthood through ART, especially IVF, is expected to present various opportunities for market expansion. However, inadequate reimbursement policies associated with this treatment may impede the market growth.

The report provides extensive competitive analysis and profiles of key market players such as Ava-Peter Clinic, MD Medical Group, and IVF Russia (The International Centre of The Reproductive Medicines).

The other players in the value chain include Vitrolife AB, EMD Serono, Inc., Irvine Scientific, Cooper Surgical, Inc., Cook Medical, Inc., and Thermo Fisher Scientific, Inc.

Russia IVF Market, By End User, 2015 ($Million)

RUSSIA IVF MARKET, BY END USER, 2015 ($MILLION)

Get more information on this report : Request Sample Pages

Clinical research institutes possess high market potential for growth in the Russian market, owing to increase in awareness and availability of different ARTs, such as ovulation induction (OI), gamete intrafallopian transfer (GIFT), preimplantation genetic diagnosis (PGD) and others; and rise in healthcare and research expenditure.

Key Benefits

  • This report provides a detailed quantitative analysis of the current market trends from 2014 to 2022 to identify the prevailing opportunities.
  • Market estimations are based on comprehensive analysis of the key developments in the industry.
  • In-depth analysis based on drugs and end users assists to understand the market and facilitates strategic business planning.
  • The developmental strategies adopted by key manufacturers are enlisted to understand the competitive scenario of the market.

Russia IVF Market Key Segments:

By End User

  • Fertility Clinics
  • Hospitals
  • Surgical Centers
  • Clinical Research Institutes

By Cycle Type

  • Fresh IVF cycles (Non-donor)
  • Thawed IVF cycles (Non-donor)
  • Donor Egg IVF Cycles

By Type

  • Non-ICSI IVF Cycles
  • ICSI-assisted IVF Cycles

By Drug

  • Clomiphene Citrate
  • Aromatase Inhibitors
  • Gonadotropins & Gonadotropin-releasing Hormone
  • Follicle-stimulating Hormone
  • Progesterone
  • Others

By Mode of Administration

  • Oral
  • Injectable
  • Vaginal
 

Chapter: 1 RUSSIA IVF MARKET

1.1. EUROPE IVF MARKET (REVENUE AND NUMBER OF CYCLES)
1.2. RUSSIA IVF MARKET (REVENUE AND NUMBER OF CYCLES)

1.2.1. Market size and forecast
1.2.2. Russia IVF market, by end user

1.2.2.1. Market size and forecast
1.2.2.2. Fertility clinics
1.2.2.3. Hospitals
1.2.2.4. Surgical centers
1.2.2.5. Clinical research institutes

1.2.3. Russia IVF market, by cycle type

1.2.3.1. Market size and forecast
1.2.3.2. Fresh IVF cycles (non-donor)
1.2.3.3. Thawed IVF cycles (non-donor)
1.2.3.4. Donor egg IVF cycles

1.2.4. Russia IVF market, by type

1.2.4.1. Market size and forecast
1.2.4.2. Non-ICSI IVF cycles
1.2.4.3. ICSI-assisted IVF cycles

1.2.5. Russia IVF market by pharmacological modality

1.2.5.1. Overview
1.2.5.2. Key trends
1.2.5.3. Market size and forecast
1.2.5.4. Duration of therapy
1.2.5.5. Segmentation of drugs for IVF

1.2.5.5.1. Clomiphene citrate
1.2.5.5.2. Aromatase inhibitors
1.2.5.5.3. Gonadotropins & gonadotropin-releasing hormone (GnRH)
1.2.5.5.4. Follicle-stimulating hormone (FSH)
1.2.5.5.5. Progesterone
1.2.5.5.6. Others

1.2.5.6. Mode of administration

1.2.5.6.1. Oral
1.2.5.6.2. Injectable
1.2.5.6.3. Vaginal

1.2.6. Market dynamics

1.2.6.1. Drivers

1.2.6.1.1. Rise in popularity of fertility tourism
1.2.6.1.2. Advanced IVF facilities and treatment options

1.2.6.2. Restraint

1.2.6.2.1. Inadequate reimbursement policies

1.2.7. Regulatory issues, legislations, and authorities
1.2.8. Insurance reimbursement scenario

Chapter: 2 COMPANY PROFILES

2.1. AVA-PETER CLINIC

2.1.1. Company overview
2.1.2. Company snapshot
2.1.3. Product portfolio

2.2. MD MEDICAL GROUP INVESTMENTS PLC (MD MEDICAL GROUP)

2.2.1. Company overview
2.2.2. Company snapshot
2.2.3. Operating business segments
2.2.4. Product portfolio
2.2.5. Business performance
2.2.6. Key strategic moves and developments

2.3. IVF RUSSIA (THE INTERNATIONAL CENTRE OF THE REPRODUCTIVE MEDICINES)

2.3.1. Company overview
2.3.2. Company snapshot
2.3.3. Operating business segments

LIST OF TABLES

TABLE 1. RUSSIA IVF MARKET, VALUE AND VOLUME, 2014-2022 ($MILLION AND THOUSAND CYCLES)
TABLE 2. RUSSIA IVF MARKET VALUE, BY END USER, 2014-2022 ($MILLION)
TABLE 3. RUSSIA IVF MARKET VOLUME, BY END USER, 2014-2022 (THOUSAND CYCLES)
TABLE 4. RUSSIA IVF MARKET VALUE, BY CYCLE TYPE, 2014-2022 ($MILLION)
TABLE 5. RUSSIA IVF MARKET VOLUME, BY CYCLE TYPE, 2014-2022 (THOUSAND CYCLES)
TABLE 6. RUSSIA IVF MARKET VALUE, BY TYPE, 2014-2022 ($MILLION)
TABLE 7. RUSSIA IVF MARKET VALUE, BY DRUG, 2014-2022 ($MILLION)
TABLE 8. RUSSIA IVF MARKET VALUE, BY MODE OF ADMINISTRATION, 2014-2022 ($MILLION)
TABLE 9. CLOMIPHINE CITRATE: KEY BRAND NAMES
TABLE 10. AROMATASE INHIBITORS: KEY BRAND NAMES
TABLE 11. GONADOTROPINS & GNRH: KEY BRAND NAMES
TABLE 12. FSH: KEY BRAND NAMES
TABLE 13. PROGESTERONE: KEY BRAND NAMES
TABLE 14. IVF TREATMENT: KEY ORAL MEDICATIONS
TABLE 15. IVF TREATMENT: KEY INJECTABLE (SUBCUTANEOUS AND INTRAMUSCULAR) MEDICATIONS
TABLE 16. IVF TREATMENT: KEY VAGINAL MEDICATIONS
TABLE 17. AVA PETER CLINIC: COMPANY SNAPSHOT
TABLE 18. AVA PETER CLINICS: PRODUCT PORTFOLIO
TABLE 19. MDMG: COMPANY SNAPSHOT
TABLE 20. MDMG: OPERATING SEGMENTS
TABLE 21. MCRM: COMPANY SNAPSHOT

LIST OF FIGURES

FIGURE 1. EUROPE IVF SERVICE MARKET VALUE, 2014-2022 ($MILLION)
FIGURE 2. EUROPE IVF MARKET VOLUME, 2014-2022 (THOUSAND CYCLES)
FIGURE 3. RUSSIA IVF MARKET VALUE FOR FERTILITY CLINICS, 2014-2022 ($MILLION)
FIGURE 4. RUSSIA IVF MARKET VOLUME FOR FERTILITY CLINICS, 2014-2022 (THOUSAND CYCLES)
FIGURE 5. RUSSIA IVF MARKET VALUE FOR HOSPITALS, 2014-2022 ($MILLION)
FIGURE 6. RUSSIA IVF MARKET VOLUME FOR HOSPITALS, 2014-2022 (THOUSAND CYCLES)
FIGURE 7. RUSSIA IVF MARKET VALUE FOR SURGICAL CENTERS, 2014-2022 ($MILLION)
FIGURE 8. RUSSIA IVF MARKET VOLUME FOR SURGICAL CENTERS, 2014-2022 (THOUSAND CYCLES)
FIGURE 9. RUSSIA IVF MARKET VALUE FOR CLINICAL RESEARCH INSTITUTES, 2014-2022 ($MILLION)
FIGURE 10. RUSSIA IVF MARKET VOLUME FOR CLINICAL RESEARCH INSTITUTES 2014-2022 (THOUSAND CYCLES)
FIGURE 11. RUSSIA IVF MARKET VALUE FOR FRESH IVF CYCLES (NON-DONOR), 2014-2022 ($MILLION)
FIGURE 12. RUSSIA IVF MARKET VOLUME FOR FRESH IVF CYCLES (NON-DONOR), 2014-2022 (THOUSAND CYCLES)
FIGURE 13. RUSSIA IVF MARKET VALUE FOR THAWED IVF CYCLES (NON-DONOR), 2014-2022 ($MILLION)
FIGURE 14. RUSSIA IVF MARKET VOLUME FOR THAWED IVF CYCLES (NON-DONOR), 2014-2022 (THOUSAND CYCLES)
FIGURE 15. RUSSIA IVF MARKET VALUE FOR DONOR EGG IVF CYCLES, 2014-2022 ($MILLION)
FIGURE 16. RUSSIA IVF MARKET VOLUME FOR DONOR EGG IVF CYCLES, 2014-2022 (THOUSAND CYCLES)
FIGURE 17. RUSSIA IVF MARKET VALUE FOR NON-ICSE IVF CYCLES, 2014-2022 ( $MILLION)
FIGURE 18. RUSSIA IVF MARKET VALUE FOR ICSE-ASSISTED IVF CYCLES, 2014-2022 ($MILLION)
FIGURE 19. RUSSIA IVF MARKET BY PHARMACOLOGICAL MODALITY
FIGURE 20. RUSSIA IVF MARKET VALUE FOR CLOMIPHINE CITRATE, 2014-2022 ($MILLION)
FIGURE 21. RUSSIA IVF MARKET VALUE FOR AROMATASE INHIBITORS, 2014-2022 ($MILLION)
FIGURE 22. RUSSIA IVF MARKET VALUE FOR GONADOTROPINS AND GNRH, 2014-2022 ($MILLION)
FIGURE 23. RUSSIA IVF MARKET VALUE FOR FSH, 2014-2022 ($MILLION)
FIGURE 24. RUSSIA IVF MARKET VALUE FOR PROGESTERONE, 2014-2022 ($MILLION)
FIGURE 25. RUSSIA IVF MARKET VALUE FOR OTHER DRUGS, 2014-2022 ($MILLION)
FIGURE 26. RUSSIA IVF MARKET VALUE FOR ORAL MODE OF ADMINISTRATION, 2014-2022 ($MILLION)
FIGURE 27. RUSSIA IVF MARKET VALUE FOR INJECTABLE MODE OF ADMINISTRATION, 2014-2022 ($MILLION)
FIGURE 28. RUSSIA IVF MARKET VALUE FOR VAGINAL MODE OF ADMINISTRATION, 2014-2022 ($MILLION)

 

In vitro fertilization (IVF) comprises fertilization of the male and female gametes to form the human embryo outside the womb, i.e., in a petri dish in laboratory settings. This embryo is then transferred to the uterus for gestation. It is one of the most popular assisted reproductive technologies (ART) for successful fertilization. IVF treatment is preferred for women with missing or blocked fallopian tubes. In addition, structural causes that cause infertility such as fibroids, endometriosis, cervical problems, and polycystic ovary syndrome also require IVF intervention

The Russia IVF market is anticipated to witness considerable growth in the future, owing to rise in incidence of infertility cases, emergent trend of late pregnancies among women, technological advancements in IVF procedures, and rise in gamete donation. Furthermore, low cost of clinical settings for IVF treatments in Russia as compared to the U.S., UK, and other established markets; surge in popularity of medical & fertility tourism; and advanced IVF facilities & treatment options are anticipated to supplement the market growth.

However, inadequate reimbursement policies for IVF treatment are anticipated to impede the market growth. Moreover, increase in interest of single parents and same-sex couples to experience parenthood through IVF is expected to present lucrative opportunities for market expansion. At present, the fertility clinics are the largest end users of IVF treatment, followed by hospitals, surgical centers, and clinical research institutes. The clinical research institute end-user segment is expected to exhibit the highest growth rate throughout the forecast period.

 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 

Request Sample

Request Customization

Request sample

OR

Purchase Full Report of
Russia In Vitro Fertilization (IVF) Market- Opportunity Analysis and Industry Forecast, 2014-2022

  • Data Pack
  • $1635
  • Restricted to one authorized users
  • One print only
  • Available in Excel
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $2535
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $3045
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprise
    License/PDF

  • $4246
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Access reports on all emerging
market of Life Sciences on Knowledge Tree Platform
Free Demo